Ever Fortune.AI Co., Ltd. AI Stock Analysis
Ever Fortune.AI Co., Ltd. (6841) AI Stock Analysis
Ever Fortune.AI Co., Ltd.
(TPEx:6841)
Ever Fortune.AI scores in the lower-middle range. Its biggest strength is a debt-free, equity-rich balance sheet backing rapid revenue growth and solid ~59% gross margins. However, earnings quality is the central concern: 2025 profit came mostly from below-the-line items, operating margins narrowed, operating cash flow covered less than half of net income, and free cash flow turned negative on heavy capex. Technicals compound the caution, with the price well below all key moving averages and a negative MACD, though oversold RSI and Stochastic readings hint at potential for a near-term bounce. A P/E of 70.6 leaves little room for disappointment, only partly offset by a 2.06% dividend yield and low beta. The investment case depends on management converting top-line growth into durable operating profits and positive free cash flow.
Ever Fortune.AI Co., Ltd. (6841) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 4.58B
- Dividend Yield
- 2.05%
- Average Volume (3M)
- 191.49K
- Price to Earnings (P/E)
- 104.6
- Beta (1Y)
- 0.64
- Revenue Growth
- 21.64%
- EPS Growth
- -60.19%
- Country
- TW
- Employees
- 50
- Sector
- General
- Sector Strength
- 55
- Industry
- Software - Application
Ever Fortune.AI Co., Ltd. Business Overview & Revenue Model
Company Description
Ever Fortune.AI Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of medical artificial intelligence software related products. The Company mainly provides medical big data and cloud biomedical platfor...
Ever Fortune.AI Co., Ltd. Financial Statement Overview
Summary
Ever Fortune.AI combines exceptional revenue growth (NT$378.8M in 2025, up ~12% after a near four-fold jump in 2024) and a fortress balance sheet — essentially debt-free with equity funding ~79% of assets (Balance Sheet 80) — with weaker earnings quality and cash conversion. Net income of NT$107.4M was largely driven by non-operating items, with EBIT of only NT$35.4M and operating margin compressing from 16.8% to 9.3% (Income Statement 63). Cash flow is the weak link (44): operating cash flow slipped to NT$46.8M, covering only ~43% of net income, and heavy capex of ~NT$77M pushed free cash flow back to negative NT$30.2M. ROE remains modest at ~6.4%, and equity declined year over year despite profitability.
Income Statement
63PositiveBalance Sheet
80PositiveCash Flow
44Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 382.65M | 378.81M | 337.52M | 93.98M | 53.90M | 38.24M |
| Gross Profit | 252.72M | 224.93M | 207.81M | 46.62M | 38.91M | 30.47M |
| EBITDA | 128.81M | 58.25M | 77.97M | -16.92M | 154.73M | -54.95M |
| Net Income | 64.34M | 107.40M | 30.31M | -42.04M | 136.48M | -54.20M |
Balance Sheet | ||||||
| Total Assets | 2.88B | 2.12B | 2.09B | 2.09B | 1.68B | 1.55B |
| Cash, Cash Equivalents and Short-Term Investments | 1.55B | 707.13M | 954.92M | 1.41B | 1.20B | 1.27B |
| Total Debt | 462.31M | 6.33M | 6.39M | 2.56M | 2.98M | 3.15M |
| Total Liabilities | 570.55M | 110.74M | 148.47M | 88.04M | 33.72M | 38.97M |
| Stockholders Equity | 1.58B | 1.68B | 1.87B | 1.93B | 1.65B | 1.51B |
Cash Flow | ||||||
| Free Cash Flow | -27.24M | -30.18M | 12.98M | -46.56M | -68.21M | -73.14M |
| Operating Cash Flow | 37.06M | 46.77M | 62.51M | -27.60M | -60.43M | -41.92M |
| Investing Cash Flow | 150.11M | 449.06M | -109.84M | -144.13M | 64.20M | -26.97M |
| Financing Cash Flow | 471.50M | -39.65M | -101.59M | 380.25M | -2.98M | -16.52M |
Ever Fortune.AI Co., Ltd. Peers Comparison
Overall Rating
TW:668965Neutral
TW:692258Neutral
TW:416455Neutral- TW:684154Neutral
TW:616346Neutral
TW:473739Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TW:6689 | 65Neutral | TWD 5.16B | 36.24 | ― | 2.56% | -0.73% | 16.72% |
| TW:6922 | 58Neutral | TWD 5.00B | 15.74 | ― | 2.62% | 34.63% | 57.37% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| TW:4164 | 55Neutral | TWD 4.79B | 21.84 | ― | 4.45% | 11.83% | 27.86% |
| TW:6841 | 54Neutral | TWD 4.58B | 104.64 | ― | 2.05% | 21.64% | -60.19% |
| TW:6163 | 46Neutral | TWD 5.43B | 42.55 | ― | 1.50% | 24.16% | 78.64% |
| TW:4737 | 39Underperform | TWD 4.18B | -13.55 | ― | ― | -9.37% | -132.26% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:6841 | Ever Fortune.AI Co., Ltd. | 48.80 | -16.30 | -25.04% | |
| TW:4164 | CHC Healthcare Group | 24.90 | -15.67 | -38.63% | |
| TW:4737 | Bionime Corporation | 55.70 | -6.69 | -10.72% | |
| TW:6163 | Hwacom Systems Inc | 38.50 | 11.44 | 42.28% | |
| TW:6689 | eCloudvalley Digital Technology Co., Ltd. | 78.00 | 14.33 | 22.51% | |
| TW:6922 | Neousys Technology, Inc. | 184.00 | -7.40 | -3.86% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026